Search Tag: transcatheter aortic valve implantation
2021 28 Aug
In another Hot Line session at the ESC Congress 2021, findings from the ENVISAGE-TAVI AF showed that edoxaban is non-inferior to warfarin and its analogues for adverse clinical events in patients with atrial fibrillation after transcatheter aortic valve implantation. The prevalence of pre-existing or new-onset atrial fibrillation after TAVI ranges...Read more
2019 26 Jun
Transcatheter aortic valve replacement (TAVR) is widely used to treat aortic stenosis. The treatment approach is approved by the FDA and is recommended in patients with severe symptomatic aortic stenosis and intermediate surgical risk. However, post-TAVR stroke remains a serious complication and is associated with increased mortality. While the...Read more
2018 27 Nov
Established surgical scores have limitations in delineating risk among candidates for transcatheter aortic valve implantation (TAVI). A novel 8-element geriatric assessment (GA) frailty score, developed by a team of researchers from Norway, Switzerland and the U.S., may be a useful tool for heart teams in selecting patients who will benefit most...Read more
2018 21 Aug
In this issue of HealthManagement, we shine the spotlight on two leading figures in the field of cardiology—Prof. Dr. Hüseyin Ince and Dr. Giuseppe D'Ancona—to bring together their expert views on key developments in transcatheter aortic valve implantation (TAVI), percutaneous mitral valve repair and more. Transcatheter aortic valve implantation...Read more
2016 07 Nov
A systematic review and meta-analysis published in British Medical Journal , examines the effect of TAVI versus surgical replacement of an aortic valve (SAVR) in patients with severe aortic stenosis at low and intermediate risk of perioperative death and reviews on the values and preferences of patients. TAVI has been increasingly used as...Read more